XOMA Financials
| XOMAO Preferred Stock | USD 25.35 0.03 0.12% |
XOMA |
Understanding current and past XOMA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of XOMA's financial statements are interrelated, with each one affecting the others. For example, an increase in XOMA's assets may result in an increase in income on the income statement.
XOMA Preferred Stock Summary
XOMA competes with XOMA Corp, Harrow Health, SiriusPoint, New York, and Sachem Capital. XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Xoma Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Preferred Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 98419J404 |
| Location | California; U.S.A |
| Business Address | 2200 Powell Street, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.xoma.com |
| Phone | 510 204 7200 |
| Currency | USD - US Dollar |
XOMA Key Financial Ratios
XOMA's financial ratios allow both analysts and investors to convert raw data from XOMA's financial statements into concise, actionable information that can be used to evaluate the performance of XOMA over time and compare it to other companies across industries.XOMA Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining XOMA's current stock value. Our valuation model uses many indicators to compare XOMA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across XOMA competition to find correlations between indicators driving XOMA's intrinsic value. More Info.XOMA Corporation is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for XOMA Corporation is roughly 1.79 . Comparative valuation analysis is a catch-all model that can be used if you cannot value XOMA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for XOMA's Preferred Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.XOMA Systematic Risk
XOMA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. XOMA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on XOMA correlated with the market. If Beta is less than 0 XOMA generally moves in the opposite direction as compared to the market. If XOMA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one XOMA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of XOMA is generally in the same direction as the market. If Beta > 1 XOMA moves generally in the same direction as, but more than the movement of the benchmark.
XOMA January 30, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of XOMA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of XOMA Corporation. We use our internally-developed statistical techniques to arrive at the intrinsic value of XOMA Corporation based on widely used predictive technical indicators. In general, we focus on analyzing XOMA Preferred Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build XOMA's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.3102 | |||
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 1.48 | |||
| Value At Risk | (0.52) | |||
| Potential Upside | 0.5231 |
Other Information on Investing in XOMA Preferred Stock
XOMA financial ratios help investors to determine whether XOMA Preferred Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XOMA with respect to the benefits of owning XOMA security.